Carfagno David G DO is categorized under Sports Medicines in Scottsdale, AZ and active since 2001.
Carfagno David G DO was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Sports Medicines business, which does work in the B2C market, and is classified as a Sports Medicines, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact David Carfagno at the company’s single location by writing to 10133 North 92nd St # 102, Scottsdale, Arizona AZ 85258 or by phoning (480) 664-4615. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Carfagno David G DO |
| Contact Person: | David Carfagno |
| Address: | 10133 North 92nd St # 102, Scottsdale, Arizona 85258 |
| Phone Number: | (480) 664-4615 |
| Website Address: | scottsdalesportsmedicine.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Sports Medicines |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Carfagno David G DO was started in 2001 to provide professional Sports Medicines under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact David Carfagno for inquiries that concern Carfagno David G DO by calling the company number (480) 664-4615, as your correspondence is most welcome. Additionally, the physical location of the single location of Carfagno David G DO can be found at the coordinates 33.57795,-111.88035 as well as the street address 10133 North 92nd St # 102 in Scottsdale, Arizona 85258.
For its online presence, you may visit Carfagno David G DO’s website at scottsdalesportsmedicine.com and engage with its social media outlets through on Twitter and on Facebook.